Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 3, Issue 4

2011 December - 33 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (33)

  • Article
  • Open Access
23 Citations
8,730 Views
13 Pages

Clinical Investigation of the Role of Interleukin-4 and Interleukin-13 in the Evolution of Prostate Cancer

  • Robert Goldstein,
  • Charles Hanley,
  • Jonathan Morris,
  • Declan Cahill,
  • Ashish Chandra,
  • Peter Harper,
  • Simon Chowdhury,
  • John Maher and
  • Sophie Burbridge

16 December 2011

Prostate cancer is the most common cancer in men, both in the USA and Europe. Although incurable, metastatic disease can often be controlled for years with anti-androgen therapy. Once the disease becomes castrate resistant, the median survival is 18...

  • Review
  • Open Access
37 Citations
7,904 Views
11 Pages

NF-kappaB in Lung Tumorigenesis

  • Zhenjian Cai,
  • Kam-Meng Tchou-Wong and
  • William N. Rom

14 December 2011

The development of lung cancer in humans can be divided into three steps: initiation, promotion and progression. This process is driven by alterations in related signal transduction pathways. These pathways signal the aberrant activation of NF-kappaB...

  • Review
  • Open Access
8 Citations
6,679 Views
12 Pages

14 December 2011

It is well-established that the actin cytoskeleton plays an important role in tumor development yet the contribution made by nuclear actin is ill-defined. In a recent study, nuclear actin was identified as a key mediator through which laminin type II...

  • Article
  • Open Access
10 Citations
7,260 Views
17 Pages

8 December 2011

Hsp90a’s vital role in tumour survival and progression, together with its highly inducible expression profile in gliomas and its absence in normal tissue and cell lines validates it as a therapeutic target for glioma. Hsp90a was downregulated using t...

  • Review
  • Open Access
8 Citations
9,369 Views
13 Pages

Stroma-Directed Molecular Targeted Therapy in Gastric Cancer

  • Yasuhiko Kitadai,
  • Michiyo Kodama and
  • Kei Shinagawa

8 December 2011

Recent studies in molecular and cellular biology have shown that tumor growth and metastasis are not determined by cancer cells alone, but also by a variety of stromal cells. Tumor stroma contains abundant extracellular matrix and several types of ce...

  • Article
  • Open Access
42 Citations
9,645 Views
16 Pages

Immunohistochemical Assessment of Expression of Centromere Protein—A (CENPA) in Human Invasive Breast Cancer

  • Ashish B. Rajput,
  • Nianping Hu,
  • Sonal Varma,
  • Chien-Hung Chen,
  • Keyue Ding,
  • Paul C. Park,
  • Judy-Anne W. Chapman,
  • Sandip K. SenGupta,
  • Yolanda Madarnas and
  • Harriet E. Feilotter
  • + 1 author

6 December 2011

Abnormal cell division leading to the gain or loss of entire chromosomes and consequent genetic instability is a hallmark of cancer. Centromere protein –A (CENPA) is a centromere-specific histone-H3-like variant gene involved in regulating chromosome...

  • Review
  • Open Access
27 Citations
12,556 Views
21 Pages

Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines

  • Lijin Li,
  • Peter Goedegebuure,
  • Elaine R. Mardis,
  • Matthew J.C. Ellis,
  • Xiuli Zhang,
  • John M. Herndon,
  • Timothy P. Fleming,
  • Beatriz M. Carreno,
  • Ted H. Hansen and
  • William E. Gillanders

25 November 2011

New DNA sequencing platforms have revolutionized human genome sequencing. The dramatic advances in genome sequencing technologies predict that the $1,000 genome will become a reality within the next few years. Applied to cancer, the availability of c...

  • Review
  • Open Access
30 Citations
12,111 Views
21 Pages

Transcription Inhibition as a Therapeutic Target for Cancer

  • Christine M. Stellrecht and
  • Lisa S. Chen

23 November 2011

During tumorigenesis the transformed cells lose their normal growth control mechanisms and become dependent on oncogenes’ products and pathways for survival. Treatments tailored to block the expression or function of transforming genes have shown eff...

  • Article
  • Open Access
18 Citations
8,800 Views
19 Pages

Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology

  • Leah Hennings,
  • Cecile Artaud,
  • Fariba Jousheghany,
  • Behjatolah Monzavi-Karbassi,
  • Anastas Pashov and
  • Thomas Kieber-Emmons

11 November 2011

Among the most challenging of clinical targets for cancer immunotherapy are Tumor Associated Carbohydrate Antigens (TACAs). To augment immune responses to TACA we are developing carbohydrate mimetic peptides (CMPs) that are sufficiently potent to act...

  • Review
  • Open Access
4 Citations
7,987 Views
12 Pages

Sarcoma Immunotherapy

  • Launce G. Gouw,
  • Kevin B. Jones,
  • Sunil Sharma and
  • R. Lor Randall

10 November 2011

Much of our knowledge regarding cancer immunotherapy has been derived from sarcoma models. However, translation of preclinical findings to bedside success has been limited in this disease, though several intriguing clinical studies hint at the potent...

  • Article
  • Open Access
8 Citations
10,073 Views
12 Pages

Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study

  • Camilla T. Karlsson,
  • Fredrik Wiklund,
  • Henrik Grönberg,
  • Anders Bergh and
  • Beatrice Melin

8 November 2011

Epidemiological and experimental evidence suggests that inflammation plays a role in both prostate cancer (PCa) and benign prostate hyperplasia (BPH). This study evaluates the risk of PC after transurethral resection (TURP) for BPH and estimates the...

  • Article
  • Open Access
33 Citations
19,125 Views
12 Pages

Discriminating Different Cancer Cells Using a Zebrafish in Vivo Assay

  • Karni S. Moshal,
  • Karine F. Ferri-Lagneau,
  • Jamil Haider,
  • Pooja Pardhanani and
  • TinChung Leung

31 October 2011

Despite the expanded understanding of tumor angiogenesis phenomenon and how it impacts cancer treatment outcomes, we have yet to develop a robust assay that can quickly, easily, and quantitatively measure tumor-induced angiogenesis. Since the zebrafi...

  • Article
  • Open Access
5 Citations
7,674 Views
13 Pages

Distribution of Functional Liver Volume in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus in the 1st Branch and Main Trunk Using Single Photon Emission Computed Tomography—Application to Radiation Therapy

  • Shintaro Shirai,
  • Morio Sato,
  • Yasutaka Noda,
  • Kazushi Kishi,
  • Nobuyuki Kawai,
  • Hiroki Minamiguchi,
  • Motoki Nakai,
  • Hiroki Sanda,
  • Shinya Sahara and
  • Tetsuo Sonomura
  • + 1 author

31 October 2011

Purpose: To analyze the distribution of functional liver volume (FLV) in the margin volume (MV) surrounding hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) before radiation therapy (RT) and to verify the safety of single photon...

  • Review
  • Open Access
23 Citations
8,297 Views
29 Pages

28 October 2011

Despite the use of more effective multimodal treatments in high-grade glioma (HGG), the outcome of patients affected by this disease is still dismal and recurrence is a very common event. Many therapeutic approaches, alone or combined (surgery, drugs...

  • Review
  • Open Access
2 Citations
8,282 Views
12 Pages

28 October 2011

The standard of care for the management of locally advanced esophageal cancers in the United States is chemotherapy combined with radiation, either definitively, or for those who could tolerate surgery, preoperatively before esophagectomy. Although t...

  • Review
  • Open Access
57 Citations
11,772 Views
14 Pages

Role of Radiation Therapy in the Management of Renal Cell Cancer

  • Angel I. Blanco,
  • Bin S. Teh and
  • Robert J. Amato

26 October 2011

Renal cell carcinoma (RCC) is traditionally considered to be radioresistant; therefore, conventional radiotherapy (RT) fraction sizes of 1.8 to 2 Gy are thought to have little role in the management of primary RCC, especially for curative disease. In...

  • Review
  • Open Access
104 Citations
12,479 Views
22 Pages

Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

  • Dhruba J. Bharali,
  • Imtiaz A. Siddiqui,
  • Vaqar M. Adhami,
  • Jean Christopher Chamcheu,
  • Abdullah M. Aldahmash,
  • Hasan Mukhtar and
  • Shaker A. Mousa

26 October 2011

The advent of nanotechnology has had a revolutionary impact on many aspects of 21st century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, pr...

  • Article
  • Open Access
114 Citations
15,969 Views
15 Pages

Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up

  • Tatsuya Ohno,
  • Tatsuaki Kanai,
  • Satoru Yamada,
  • Ken Yusa,
  • Mutsumi Tashiro,
  • Hirofumi Shimada,
  • Kota Torikai,
  • Yukari Yoshida,
  • Yoko Kitada and
  • Takashi Nakano
  • + 2 authors

26 October 2011

Carbon ion radiotherapy (C-ion RT) offers superior dose conformity in the treatment of deep-seated tumors compared with conventional X-ray therapy. In addition, carbon ion beams have a higher relative biological effectiveness compared with protons or...

  • Article
  • Open Access
13 Citations
13,524 Views
19 Pages

Helical Tomotherapy in Children and Adolescents: Dosimetric Comparisons, Opportunities and Issues

  • Maurizio Mascarin,
  • Francesca Maria Giugliano,
  • Elisa Coassin,
  • Annalisa Drigo,
  • Paola Chiovati,
  • Andrea Dassie,
  • Giovanni Franchin,
  • Emilio Minatel and
  • Mauro Gaetano Trovò

25 October 2011

Helical Tomotherapy (HT) is a highly conformal image-guided radiation technique, introduced into clinical routine in 2006 at the Centro di Riferimento Oncologico Aviano (Italy). With this new technology, intensity-modulated radiotherapy (IMRT) is del...

  • Article
  • Open Access
13 Citations
8,621 Views
19 Pages

25 October 2011

Therapeutic cancer vaccines have the potential to generate a long lasting immune response that will destroy tumor cells with specificity and safety, in contrast to many other current cancer therapies. Clinical success to date has been limited by a nu...

  • Review
  • Open Access
8 Citations
8,052 Views
15 Pages

24 October 2011

Cancer stem cells are defined as a subpopulation of cells within a tumor that are capable of self-renewal and differentiation into the heterogeneous cell lineages that comprise the tumor. Many studies indicate that cancer stem cells may be responsibl...

  • Review
  • Open Access
58 Citations
17,761 Views
36 Pages

21 October 2011

Understanding the mechanisms that control stress is central to realize how cells respond to environmental and physiological insults. All the more important is to reveal how tumour cells withstand their harsher growth conditions and cope with drug-ind...

  • Article
  • Open Access
18 Citations
8,246 Views
12 Pages

Forced Expression of ZNF143 Restrains Cancer Cell Growth

  • Hiroto Izumi,
  • Yoshihiro Yasuniwa,
  • Masaki Akiyama,
  • Takahiro Yamaguchi,
  • Akihiro Kuma,
  • Noriaki Kitamura and
  • Kimitoshi Kohno

19 October 2011

We previously reported that the transcription factor Zinc Finger Protein 143 (ZNF143) regulates the expression of genes associated with cell cycle and cell division, and that downregulation of ZNF143 induces cell cycle arrest at G2/M. To assess the f...

  • Review
  • Open Access
49 Citations
15,611 Views
15 Pages

The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

  • Dingzhi Wang,
  • Dianren Xia and
  • Raymond N. DuBois

14 October 2011

Colorectal cancer (CRC) is now the second-leading cause of cancer deaths in the USA. Colorectal cancer progression and metastasis depends on the orchestration of the aberrant signaling pathways that control tumor cell proliferation, survival and migr...

  • Article
  • Open Access
9 Citations
7,787 Views
14 Pages

The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer

  • Simon N.S. Louis,
  • Laurie T.C. Chow,
  • Naghmeh Varghayee,
  • Linda A. Rezmann,
  • Albert G. Frauman and
  • William J. Louis

11 October 2011

Angiotensin II (Ang II), the main effector of the renin angiotensin system, acts upon two distinct transmembrane receptors, the Ang II type 1 and the type 2 (AT2-) receptor, to induce promotion and inhibition of ERK2 phosphorylation. The AT2-receptor...

  • Review
  • Open Access
84 Citations
14,487 Views
18 Pages

Targeted Radionuclide Therapy

  • Devrim Ersahin,
  • Indukala Doddamane and
  • David Cheng

11 October 2011

Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectivenes...

  • Review
  • Open Access
38 Citations
13,617 Views
26 Pages

Biomarkers in Prostate Cancer Epidemiology

  • Mukesh Verma,
  • Payal Patel and
  • Mudit Verma

30 September 2011

Understanding the etiology of a disease such as prostate cancer may help in identifying populations at high risk, timely intervention of the disease, and proper treatment. Biomarkers, along with exposure history and clinical data, are useful tools to...

  • Review
  • Open Access
114 Citations
12,983 Views
25 Pages

Combined Hyperthermia and Radiotherapy for the Treatment of Cancer

  • Punit Kaur,
  • Mark D. Hurwitz,
  • Sunil Krishnan and
  • Alexzander Asea

30 September 2011

Radiotherapy is used to treat approximately 50% of all cancer patients, with varying success. Radiation therapy has become an in­tegral part of modern treatment strategies for many types of cancer in recent decades, but is associated with a risk of l...

  • Article
  • Open Access
71 Citations
10,402 Views
14 Pages

28 September 2011

Tumor-associated macrophages (TAMs) are a major cellular component in the tumor microenvironment of many solid tumors. The functional competence of TAMs varies depending on the type of tumors and their respective microenvironments. The classically ac...

  • Review
  • Open Access
81 Citations
14,119 Views
22 Pages

Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma

  • Manuela Liguori,
  • Graziella Solinas,
  • Giovanni Germano,
  • Alberto Mantovani and
  • Paola Allavena

28 September 2011

Tumor-Associated Macrophages (TAM) are key components of the reactive stroma of tumors. In most, although not all cancers, their presence is associated with poor patient prognosis. In addition to releasing cytokines and growth factors for tumor and e...

  • Article
  • Open Access
25 Citations
8,472 Views
11 Pages

Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice

  • Xi Zheng,
  • Xiao-Xing Cui,
  • Tin Oo Khor,
  • Ying Huang,
  • Robert S DiPaola,
  • Susan Goodin,
  • Mao-Jung Lee,
  • Chung S Yang,
  • Ah-Ng Kong and
  • Allan H. Conney

28 September 2011

In the present study, we determined the effects of a γ-tocopherol-rich mixture of tocopherols (γ-TmT) on the growth and apoptosis of cultured human prostate cancer LNCaP cells. We also determined the effects of dietary γ-TmT on the formation and grow...

  • Article
  • Open Access
19 Citations
8,382 Views
12 Pages

DNA Methylation and the HOXC6 Paradox in Prostate Cancer

  • Anna Vinarskaja,
  • Masanori Yamanaka,
  • Marc Ingenwerth and
  • Wolfgang A. Schulz

27 September 2011

Overexpression of the classical homeobox transcription factor HOXC6 is frequent in prostate cancers and correlates with adverse clinical parameters. Since surprisingly many HOXC6 target genes are downregulated in prostate cancer, it has been posited...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694